Viatris, Inc. (VTRS)
16.54
+0.22
(+1.38%)
USD |
NASDAQ |
Aug 24, 16:00
16.54
0.00 (0.00%)
After-Hours: 20:00
Viatris Price to Book Value : 1.340 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.322 |
| August 20, 2026 | 1.306 |
| August 19, 2026 | 1.316 |
| August 18, 2026 | 1.310 |
| August 17, 2026 | 1.315 |
| August 14, 2026 | 1.315 |
| August 13, 2026 | 1.299 |
| August 12, 2026 | 1.304 |
| August 11, 2026 | 1.319 |
| August 10, 2026 | 1.319 |
| August 07, 2026 | 1.331 |
| August 06, 2026 | 1.320 |
| August 05, 2026 | 1.430 |
| August 04, 2026 | 1.434 |
| August 03, 2026 | 1.428 |
| July 31, 2026 | 1.422 |
| July 30, 2026 | 1.439 |
| July 29, 2026 | 1.444 |
| July 28, 2026 | 1.447 |
| July 27, 2026 | 1.429 |
| July 24, 2026 | 1.397 |
| July 23, 2026 | 1.400 |
| July 22, 2026 | 1.378 |
| July 21, 2026 | 1.425 |
| July 20, 2026 | 1.376 |
| Date | Value |
|---|---|
| July 17, 2026 | 1.401 |
| July 16, 2026 | 1.404 |
| July 15, 2026 | 1.351 |
| July 14, 2026 | 1.321 |
| July 13, 2026 | 1.328 |
| July 10, 2026 | 1.318 |
| July 09, 2026 | 1.324 |
| July 08, 2026 | 1.350 |
| July 07, 2026 | 1.374 |
| July 06, 2026 | 1.361 |
| July 02, 2026 | 1.353 |
| July 01, 2026 | 1.311 |
| June 30, 2026 | 1.286 |
| June 29, 2026 | 1.289 |
| June 26, 2026 | 1.297 |
| June 25, 2026 | 1.277 |
| June 24, 2026 | 1.266 |
| June 23, 2026 | 1.251 |
| June 22, 2026 | 1.222 |
| June 18, 2026 | 1.221 |
| June 17, 2026 | 1.250 |
| June 16, 2026 | 1.274 |
| June 15, 2026 | 1.296 |
| June 12, 2026 | 1.309 |
| June 11, 2026 | 1.296 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pfizer Inc. | 1.872 |
| Eli Lilly & Co. | 34.67 |
| Merck & Co., Inc. | 8.873 |
| Bristol Myers Squibb Co. | 6.161 |
| Johnson & Johnson | 7.739 |
Price to Book Value Related Metrics
| PS Ratio | 1.306 |
| Price to Free Cash Flow | 10.67 |
| Price | 16.54 |
| Earnings Yield | -2.16% |
| Market Cap | 19.11B |
| Operating PE Ratio | 13.48 |
| Normalized PE Ratio | 32.78 |